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response. Thus, viruses exploit
mammalian receptors for bacterial
products to achieve efficient
transmission.
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The orally transmitted retrovirus mouse mammary
tumor virus (MMTV) requires the intestinal microbiota
for persistence. Virion-associated lipopolysaccha-
ride (LPS) activates Toll-like receptor 4 (TLR4),
stimulating production of the immunosuppressive
cytokine IL-10 and MMTV evasion of host immunity.
However, the mechanisms by which MMTV associ-
ates with LPS remain unknown. We find that the viral
envelope contains the mammalian LPS-binding fac-
tors CD14, TLR4, and MD-2, which, in conjunction
with LPS-binding protein (LBP), bind LPS to the virus
and augment transmission. MMTV isolated from in-
fected mice lacking these LBPs cannot engage LPS
or stimulate TLR4 and have a transmission defect.
Furthermore, MMTV incorporation of a weak agonist
LPS from Bacteroides, a prevalent LPS source in the
gut, significantly enhances the ability of this LPS to
stimulate TLR4, suggesting that MMTV intensifies
these immunostimulatory properties. Thus, an orally
transmitted retrovirus can capture, modify, and
exploit mammalian receptors for bacterial ligands
to ensure successful transmission.
INTRODUCTION
Mousemammary tumor virus (MMTV) is a retrovirus that is trans-
mitted as an endogenous, stably integrated provirus (Mtv) or as
an exogenous virus (Goff, 2007). Exogenous MMTV is spread via
the milk of infected females and is acquired by suckling pups. In
the gut, the virus transcytoses throughMcells in Peyer’s patches
(Golovkina et al., 1999) and infects the underlying lymphoid cells,
including T and B lymphocytes. Infected T and B cells traffic to456 Cell Host & Microbe 18, 456–462, October 14, 2015 ª2015 Elsevthe mammary gland and pass the virus to the mammary gland
epithelia (Finke and Acha-Orbea, 2001). During lactation, the vi-
rus is secreted into the milk and is transmitted to the progeny.
Persistence of the virus requires commensal bacteria and
functional TLR4, as the virus is eliminated in both TLR4-deficient
specific-pathogen-free (SPF) (Jude et al., 2003) and wild-type
(WT) germ-free (GF) mice (Kane et al., 2011). A series of genetic
and biochemical experiments established that, after infiltrating
the host, the virus cloaks itself in lipopolysaccharide (LPS). The
LPS-associated virus activates TLR4, which leads to IL-6-medi-
ated production of the immunosuppressive cytokine IL-10 and
blockage of the antiviral response (Jude et al., 2003; Kane
et al., 2011). However, the nature of the virus-LPS interaction
has remained unknown. Here we report that mammalian LPS re-
ceptors are integrated in the viral envelope and bind LPS, thus
enabling the virus to activate the immune evasion pathway.RESULTS
To address whether MMTV directly binds LPS, a modified cap-
ture ELISA was used. Both anti-envelope (Env) glycoprotein an-
tibodies (Abs) and biotinylated LPS detected plate-boundMMTV
virions equally well (Figure S1), suggesting the virions directly
interact with LPS.
Mammals have multiple LPS-binding proteins (LBPs); some
transfer LPS to other proteins, while others are directly involved
in transmitting LPS-induced signals (Park and Lee, 2013). Spe-
cifically, the membrane-anchored protein CD14 binds LPS and
transfers it to the MD-2-TLR4 complex (Viriyakosol et al.,
2001). MD-2 directly binds LPS, and LPS-bound MD-2 triggers
TLR4 dimerization and activation of downstream signaling
(Park et al., 2009). Notably, in the absence of TLR4, MD-2 is
not present on the cell surface. MMTV, an enveloped retrovirus,
targets cells that express and display these LBPs (Lee et al.,
2009; Miyake, 2006; Figure S2). Thus, we proposed that the virus
acquires these proteins from the host and utilizes them to bindier Inc.
Figure 1. Mammalian LPS-Binding Receptors Are Present in MMTV Virions
(A) MMTV virions isolated from the milk of B6 wild-type (WT) and TLR4/mice were captured either by an anti-mouse TLR4 or anti-gp36Env Abs and detected
with biotinylated anti-gp36Env Abs. Error bars represent the SE of three independent experiments. Significance was calculated using a two-sample t test
(*p < 0.03).
(B) Western blot of proteins from virions purified from the milk of B6 (WT) and CD14/ females. The same density fraction isolated from uninfected milk (MMTV)
was used as a negative control. Anti-mouse CD14 Abs and anti-gp52Env Abs were used to detect CD14 and viral Env, respectively. Mouse CD14 recombinant
protein was used as a positive control for anti-CD14 Abs.
(C) Immunogold labeling of MMTV virions. (Top) MMTV virions purified from B6 (WT) (a, b, c, and d) or CD14/ (e and f) mouse milk were stained with anti-
gp52Env Abs followed by anti-mouse Ab coupled to gold particles (b and f) or anti-mouse Ab alone (a) or anti-CD14 Ab followed by anti-rat Ab coupled to gold
particles (d and e) or anti-rat Abs alone (c). (Bottom) Quantification of three independent experiments with over 50 virions examined per condition in each
experiment. Error bars represent the SE.
(D) MMTV virions isolated from the milk of mice lacking CD14, LBP, MD-2, or TLR4 and from animals deficient in all four factors were captured with anti-gp36Env
Abs bound to plastic. The ELISAwas developed either with biotinylated LPS (E. Coli, serotype EH100) (top) or anti-gp36Env Abs (bottom). Error bars represent SE
of three independent experiments. Significance was calculated using a two-sample t test (**p < 0.001).LPS. In fact, both TLR4 and CD14 were detected on purified
MMTV virions (Figures 1A–1C), supporting this idea.
To investigate the role of themammalian LPS-bindingmachin-
ery in viral acquisition of LPS, we used a genetic approach. WT
females and females devoid of MD-2, TLR4, CD14, and another
well-characterized LPS-binding factor, LBP (Park et al., 2009),Cell Hostwere infected with MMTV via intraperitoneal injection as adults.
The virions isolated from their milk were subjected to the LPS-
binding assay. Whereas virus titers were comparable among
all isolates (Figure 1D, bottom), virions produced by both
TLR4/ and MD-2/ females exhibited a significant reduction
in LPS binding (Figure 1D, top). This reduction was not observed& Microbe 18, 456–462, October 14, 2015 ª2015 Elsevier Inc. 457
Figure 2. LPS-Binding Proteins Carried by the Virus Are Essential for
Immune Activation and Efficient Transmission
(A) MMTV was isolated from the milk of the B6 (WT), CD14/ (CD14), and all-
LPS-binding-factor (All)-deficient females. Viral isolates with LPS content
normalized to 1 ng/ml via the LAL assay were added to either WT, CD14/, or
MD-2/ (MD-2) splenocytes. IL-6 in tissue culture supernatants was quan-
tified by ELISA 16 hr later. Error bars represent SE of three independent ex-
periments. Significance was calculated using a two-sample t test (**p < 0.001).
LPS, 1 ng/ml of LPS from E. Coli, serotype 055:B5.
(B) (Top) B6 (WT) mice were fostered on either WT or MD-2/ (MD-2) viremic
females for 48 hr. WT pups fostered on uninfected milk were used as a
negative control. The deletion of SAg-cognate Vb6+CD4+ T cells among CD4+
T cells was used as a readout for viral infection. X, animals confirmed as un-
infected by qPCR. (Bottom) Splenic DNA only from infected mice (not marked
with X) was analyzed for integrated proviruses by qPCR. Data are presented as
delta between the cycle threshhold (CT) obtained with MMTV-specific primers
and IFN-gamma-specific primers. Significance was calculated using a two-
sample t test (*p < 0.03, **p < 0.001).
(C) B6 mice were fostered on either BALB/cJ (WT) or BALB/cJ.LBP/ (LBP)
viremic females for 48 hr. B6 pups fostered on uninfected BALB/cJ milk were
used as a negative control. The deletion of SAg-cognate Vb6+CD4+ T cells
among CD4+ T cells was used to assess whether mice were infected. Error
bars represent SE. Significance was calculated using a two-sample t test
(***p < 0.0001).with either the LBP- or CD14-deficient virions. However, virions
obtained from all LPS-binding-factor-deficient mice completely
lost their LPS-binding properties (Figure 1D, top). Thus, even
though the MD-2-TLR4 complex is the primary LPS-binding
factor, LBP and/or CD14 also contribute to LPS binding. In
fact, the virus isolated from TLR4/ mice was able to bind
LPS (Figure 4C).
Activation of the TLR4 pathway, specifically production of
IL-6 and IL-10, is required for MMTV’s replication and success-
ful transmission, and mice lacking TLR4, CD14, IL-6, or IL-10
eliminate the virus through successive generations (Jude
et al., 2003; Kane et al., 2011). Therefore, the ability of MMTV
virions lacking LPS-binding factors to activate TLR4 was tested.
Virions lacking all LPS-binding factors on their membrane failed
to activate the TLR4 pathway (Figure 2A). In contrast, CD14-458 Cell Host & Microbe 18, 456–462, October 14, 2015 ª2015 Elsevdeficient virions induced signaling in WT cells (Figure 2A). Inter-
estingly, the presence of CD14 on either the viral particle or the
host cell enabled LPS-bound virions to elicit TLR4 signaling.
However, this activation was ablated when CD14 was absent
altogether (Figure 2A), indicating that CD14 must be present
in the system to facilitate the transfer of the virus’s LPS cargo
to the target cell.
To determine whether the reduced ability to bind LPS would
affect virus transmission in vivo, we followed the virus’s fate in
mice infected with WT and MD-2 virions. MMTV encodes for a
superantigen (v-SAg), which is essential for the virus life cycle
(Ross, 2008). Presentation of v-SAg results in the activation of
SAg-cognate T cells and their subsequent deletion (Marrack
et al., 1991). Deletion of SAg-cognate T cells is used as a readout
of successful infection, and the degree of T cell deletion roughly
correlates with the virus load (MacDearmid et al., 2006). Accord-
ingly,WTneonateswere fosteredbyeitherWTorMD-2/ viremic
females, and the presence of infectious virus was defined by the
percentage of SAg-cognate CD4+ T cells among all CD4+ T cells
(Figure 2B, top) and quantified by qPCR (Figure 2B, bottom). En-
veloped viruses, such as retroviruses, acquire their membrane as
they egress from infected cells. Therefore, virions secreted by
MD-2/ females acquire MD-2 upon one round of infection in
WT mice, diminishing the phenotypic difference between WT
and MD-2 viruses. To solve this problem, we reduced the
amount of incoming virus by exposingWTmice to infected foster
mothers for only 2 days. Even though the viral titers secreted by
WT andMD-2/ females were comparable (Figure 1D), the virus
titerwasreduced inmice infectedwith theMD-2virus (Figure2B).
In addition, more mice fostered by MD-2/ mothers remained
uninfected (4/7) compared to mice fostered by WT mothers (2/
14). Thus, MD-2 virions were significantly compromised in their
ability to establish infection, definitively linking the virus’s LPS-
binding capacity with successful transmission.
It is widely accepted that LBP solubilizes LPS aggregates
in vivo, making this bacterial ligand accessible to CD14 and
the MD-2-TLR4 receptor complex (Gutsmann et al., 2001; Hail-
man et al., 1994; Tobias et al., 1995). Even though virions
secreted by LBP/ females still bound LPS (Figure 1D), this
in vitro assay was performed with solubilized LPS. Thus, the po-
tential physiological significance of LBP in the virus-LPS interac-
tion may have been masked. To test the significance of LBP in
virus transmission, we followed the fate of the virus secreted
by LBP/ females. WT mice fostered on LBP/ mothers had
significantly reduced virus titers compared to mice fostered on
WTmothers, and 4/24 were uninfected (Figure 2C). This strongly
suggests that, likemammalian cells, virion-associated CD14 and
MD-2-TLR4 require LBP to bind LPS monomers in vivo.
LPS consists of three chemically distinct components as
follows: O-antigen, core oligosaccharide, and lipid A (Raetz
et al., 2007). There is significant structural heterogeneity in lipid
A molecules, with acyl chain length number, acyl chain length,
and phosphorylation state being the primary determinants of
their immunostimulatory properties (Trent et al., 2006). Notably,
the structure of LPS and its stimulatory properties vary drasti-
cally among Gram-negative bacteria, making the biological
properties of virus-bound LPS a necessary avenue of investiga-
tion. To address whether MMTV binds purified lipid A from
diverse bacterial species, LPS-free MMTV isolated from GFier Inc.
Figure 3. MMTV Binds the Lipid A Component of LPS from Diverse
Species and Enables Agonist LPS to Resist Inhibition by an Antago-
nist LPS
(A) LPS-free MMTV from GF MyD88/TLR4 double-deficient mice was incu-
bated with 40 ng/ml lipid A (E. coli, serotype R515) (E.c.) or R. sphaeroides
(R.s.) and pelleted through a 30% sucrose cushion. The amount of bound
endotoxin was quantified by the LAL assay (left). The ability of virus-bound or
free lipid A (normalized to 1 ng/ml via the LAL assay) to stimulate IL-6 pro-
duction by B6 (WT) splenocytes wasmeasured by ELISA (right). Neither E.c. or
R.s. lipid A elicit IL-6 in MD-2/ splenocytes. Error bars represent SE of three
independent experiments. Significance was calculated using a two-sample
t test. NS, non-significant.
(B) LPS from E. coli serotype 055:B5 (at 5, 50, and 100 ng/ml) or intact SPF-
MMTV virions (at 5 ng/ml endotoxin) was added to B6 splenocytes alone or
together with increasing concentration of R.s. lipid A. IL-6 in tissue culture
supernatants was quantified by ELISA 16 hr later. X is the factor by which R.s.
lipid A concentration was increased relative to E.c. LPS. Error bars represent
SE of three independent experiments. Significance was calculated using a
paired t test (*p < 0.05).mice was incubated with lipid A from either Escherichia coli
(strong TLR4 agonist [Raetz and Whitfield, 2002]) or Rhodo-
bacter (R) sphaeroides (TLR4 antagonist [Kutuzova et al.,
2001]). MMTV bound both E. coli and R. sphaeroides lipid A to
an equal degree (Figure 3A). However, only virus-bound E. coli
lipid A activated TLR4 signaling (Figure 3A). Thus, MMTV does
not discriminate between agonist and antagonist LPS/lipid A
types for binding, but requires a TLR4 agonist to trigger TLR4
signaling.
MMTV-bound LPS is more immunopotent than virus-free LPS
(Kane et al., 2011), indicating that binding of LPS to the viral
membrane amplifies LPS-induced TLR4 activation. With this in
mind and recognizing that R. sphaeroides lipid A antagonizes
activation of TLR4 by agonist LPS (Kutuzova et al., 2001), weCell Hostsought to determine whether virally bound LPS was protected
from this inhibition. Indeed, R. sphaeroides lipid A blocked
TLR4 activation by free E. coli LPS, but virus-bound LPS resisted
this inhibition (Figure 3B). As competitive inhibition of free LPS by
R. sphaeroides lipid A is concentration dependent (Manthey
et al., 1993), the most parsimonious explanation for this result
is that binding of LPS to the virion increases the effective local
concentration, making MMTV-bound LPS more resistant to inhi-
bition by R. sphaeroides lipid A.
The majority of Gram-negative commensals that populate
the mouse and healthy human gut are of the Bacteroides genus
(Human Microbiome Project Consortium, 2012) and synthesize
relatively weak TLR4 agonists (Figure 4A). Since MMTV must
activate TLR4 to propagate within the host, we hypothesized
that the virus must potentiate weak agonist LPS. First, it was
determined that MMTV binds physiologically relevant LPS from
the human commensal Bacteroides thetaiotaomicron (B. theta)
to the same extent as E. coli LPS, one of the strongest TLR4 ag-
onists (Figure 4B). Second, GF-MMTV virions bound to B. theta
LPS significantly strengthened the immunopotency of this
commensal ligand similar to E. coli LPS (Figure 4C). Moreover,
this phenomenon was observed with LPS species purified
directly from MMTV virions (Figure 4D), suggesting that MMTV
has the ability to intensify the immunostimulatory properties of
agonistic commensal LPS found in the mouse gut.
Internalization of Gram-negative bacteria or LPS by innate im-
mune cells activates a non-canonical inflammasome pathway
(Kayagaki et al., 2013). This activation leads to the production
and secretion of the inflammatory cytokine IL-1b, which is known
to induce IL-6 (Cahill and Rogers, 2008). To determine whether
the non-canonical inflammasome pathway was responsible
for the increased immunopotency of virus-bound LPS, we
examined virus-elicited IL-6 induction in WT and caspase 1/4-
deficient mice, which lack both canonical and non-canonical
pathways (Figure 4E). Virus-bound LPS maintained its immu-
nopotency in caspase1/4-deficient splenocytes, suggesting
that inflammasome-dependent activation does not explain the
enhanced immunopotency of virus-bound LPS.
DISCUSSION
Although it has been noted previously that enveloped viruses ac-
quire host proteins as they bud from the cell (Bubbers and Lilly,
1977; Cantin et al., 2005), few studies have linked the signifi-
cance of this incorporation to virus replication, transmission,
and pathogenesis. HIV-1 selectively incorporates the MHC class
II glycoprotein within its membrane and uses it to accelerate en-
try into human T lymphocytes (Bastiani et al., 1997; Cantin et al.,
1997). HTLV-1 displays the complement regulatory proteins
CD59 and CD55 on its surface to evade complement-mediated
lysis (Spear et al., 1995). In addition, virion-associated MHC
class I and class II molecules impact the ability of HIV virions
to trigger cell death (Esser et al., 2001). In the case of both
HIV-1 and HTLV-1, however, the effects of the host-derived
membrane proteins on virus infectivity and pathogenesis were
demonstrated only in vitro. In this study, we show that incorpo-
ration of mammalian LBPs by an enveloped retrovirus enables
the virus to bind LPS and evade the anti-retroviral immune
response.& Microbe 18, 456–462, October 14, 2015 ª2015 Elsevier Inc. 459
Figure 4. MMTV Augments the Immunopotency of Commensal LPS
(A) The immunostimulatory properties of LPS from B. theta and E. coli (serotype 055:B5) were compared by IL-6 ELISA after the addition to B6 (WT) and MD-2
splenocytes. Error bars represent SE of three independent experiments. Significance was calculated using a two-sample t test (**p < 0.001).
(B) Binding of biotinylated B. theta and E. coli (serotype O26) LPS by SPF-MMTV virions captured to plastic with anti-gp36Env Abs was measured in serial
dilutions. Error bars represent SE of three independent experiments. Significance was calculated using a two-way ANOVA. NS, non-significant.
(C) B. theta or E. coli (serotype O26) LPS (at 40 ng/ml endotoxin) was incubated with or without GF-MMTV and spun down via 30% sucrose cushion. Endotoxin
levels were measured in pelleted fractions using LAL assay. Fractions with no virus added had no detectable LPS (not shown). Virus-LPS pelleted fractions were
added to B6 splenocytes at an endotoxin concentration of 71 pg/ml. The amount of secreted IL-6 was measured in tissue culture supernatants 16 hr later. In
separate cultures, virus-free B. theta and E. coli LPS were added to B6 splenocytes at the same endotoxin concentration. Error bars represent SE of three
independent experiments. Significance was calculated using a paired t test (*p < 0.03 and **p < 0.001).
(D) LPS species isolated fromSPF-MMTV virionswere added to B6 splenocytes as free form (viral LPS) or bound to SPF-MMTV virions at 35 pg/ml. The amount of
secreted IL-6 was used as a readout for TLR4 activation. Error bars represent SE of three independent experiments. Significance was calculated using a paired
t test (*p < 0.03).
(E) IL-6 secretion elicited by SPF-MMTV virions in B6 (WT), Caspase 1/4/ (Caspase 1/4), or MD-2/ (MD-2) splenocytes or by E. coli (serotype 055:B5) LPS
from Sigma (S) or Enzo Life Sciences (E) was measured by ELISA. Endotoxin concentration of 1 ng/ml in all samples was verified by the LAL assay. Error bars
represent SE of three independent experiments. Significance was calculated using a paired t test (**p < 0.001).The most abundant commensal Gram-negative bacterial spe-
cies within the human and mouse gastrointestinal tract produce
LPS that are weak TLR4 agonists (Human Microbiome Project
Consortium, 2012). However, when MMTV binds commensal
LPS derived from B. theta, it strengthens this LPS immunopo-
tency to such an extent that it exceeds the immunopotency of
E. coliLPS, apotent TLR4agonist (Figure 4C).How the virusmod-
ulates LPS potency remains to be elucidated and will require
further investigation. Nevertheless, a few possibilities can be
considered. First, LPS aggregates on the viral surface might
strengthen TLR4 activation, as aggregated but not monomeric
endotoxin activates TLR4 signaling at similar concentrations
(Mu¨ller et al., 2003). Second, virion bound LPSmayhave a greater
effective concentration than free LPS, resulting in enhanced im-
munopotency. Third, delivery of LPS bound to the surface of the
viral particle stabilizes or prolongs the ligand’s interaction with460 Cell Host & Microbe 18, 456–462, October 14, 2015 ª2015 Elsevthe cell membrane, facilitating dimerization of MD-2-TLR4 com-
plexes. The latter events potentially can occur on the cell surface
or inside the endocytic compartment where functional TLR4 also
is located (Kagan et al., 2008; Tanimura et al., 2008).
The phenomenon of LPS exploitation is not restricted to
MMTV, as other enteric viruses from completely different genera,
such as poliovirus, also utilize LPS to enhance their environ-
mental fitness and infectivity (Kuss et al., 2011; Robinson et al.,
2014). Many non-enveloped enteric viruses target cells that ex-
press LBPs (Iwasaki et al., 2002; Neal et al., 2006), and some
were reported to encase themselves within the host cell mem-
brane (Chen et al., 2015; Feng et al., 2013). Thus, it is possible
that even naked viruses could potentially exploit host LPS recep-
tors for their benefit. Further studies of this phenomenon may
lead to approaches for the prevention and treatment of some
viral infections.ier Inc.
EXPERIMENTAL PROCEDURES
Mice
All animals were bred and maintained at the animal facility of The University of
Chicago. SPF MMTV-infected and uninfected C3H/HeN were maintained in
our colony. TLR4/ C57BL10/ScNJ (Poltorak et al., 1998), B6.CD14/
(Moore et al., 2000), B6.IL-1R1/ (Glaccum et al., 1997), BALB/cJ.LBP/
(Jack et al., 1997), B6.Caspase 1/4/ (Kuida et al., 1995), BALB/cJ, and B6
mice were obtained from The Jackson Laboratory. B6.MD-2/ mice (Nagai
et al., 2002) were crossed to B6 mice for four generations before the
MD-2/ was fixed at homozygosity. BALB/cJ.LBP/ were crossed to B6
mice for six generations and then crossed to B6.CD14/MD-2/TLR4 triple-defi-
cient mice and intercrossed to generate B6.LBP/CD14/MD-2/TLR4
quadruple-deficient mice. GF C3H/HeN.MyD88/TLR4 double-deficient mice
have been reported previously (Kane et al., 2011). The studies described
here were reviewed and approved by the Animal Care and Use Committee
at The University of Chicago.
Detection of TLR4 on MMTV Virions
MMTV(LA) viral variant (Golovkina et al., 1997) was used in these studies. A
capture ELISA was developed to detect TLR4 in virions. Briefly, anti-mouse
TLR4 Abs (BioLegend) and anti-gp36Env Ab (Purdy et al., 2003) were bound
to a 96-well plate overnight. After blocking, purified virions were added to
the capture Abs and the reactions were developed with biotinylated anti-
gp36Env Abs.
Detection of CD14 in Purified Virions
MMTV virions isolated from the milk of infected B6 and B6.CD14/ mice, as
well as virus density fractions isolated from the milk of uninfected B6 females,
were subjected to western blot analysis using anti-mouse CD14 (Santa Cruz
Biotechnology) and anti-gp52Env Abs (Purdy et al., 2003).
Transmission Electron Microscopy
Purifiedmilk-borne virions were placed on glow discharge carbon-coated gold
grids and incubated with either mouse anti-gp52Env or rat anti-CD14 Abs fol-
lowed by anti-mouse or anti-rat Abs coupled to gold-conjugated Abs, respec-
tively. Samples were fixed with glutaraldehyde and stained with uranyl acetate
and examined under 300KV at FEI Tecnai F30.
MMTV-LPS Capture ELISA
Anti-gp36Env Abs were bound to 96-well plates and incubated with purified
SPF-MMTV virions. ELISA was developed with either biotinylated LPS or bio-
tinylated anti-gp36Env Abs.
MMTV Infection
To compare transmission of MD-2+ and MD-2 virions, as well as LBP and
LPB+ virions, newborn B6 mice were allowed to suckle on infected WT,
MD-2/, or LBP/ females. Deletion of SAg-cognate T cells was used as a
readout for MMTV infection, and qPCR was used to quantify viral titers.
LPS Binding to GF-MMTV Virions
Binding of TLR4/MyD88 double-deficient GF-MMTV virions to E. coli lipid A,
R. sphaeroides lipid A,B. theta LPS, or E. coli LPSwas performed as described
previously (Kane et al., 2011). Endotoxin concentration was quantified via
Limulus amebocyte lysate (LAL) assay.
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